4-70601652-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016519.6(AMBN):c.529G>A(p.Glu177Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016519.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMBN | NM_016519.6 | c.529G>A | p.Glu177Lys | missense_variant, splice_region_variant | 6/13 | ENST00000322937.10 | NP_057603.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMBN | ENST00000322937.10 | c.529G>A | p.Glu177Lys | missense_variant, splice_region_variant | 6/13 | 1 | NM_016519.6 | ENSP00000313809.6 | ||
AMBN | ENST00000449493.2 | c.484G>A | p.Glu162Lys | missense_variant, splice_region_variant | 6/13 | 5 | ENSP00000391234.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249506Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134894
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461352Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727000
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.529G>A (p.E177K) alteration is located in exon 6 (coding exon 6) of the AMBN gene. This alteration results from a G to A substitution at nucleotide position 529, causing the glutamic acid (E) at amino acid position 177 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at